Association française des Centres régionaux de pharmacovigilance, pp.351-355, 2016. ,
L???apport de la pharmaco-??pid??miologie ?? la pharmacovigilance, Th??rapie, vol.71, issue.2, pp.203-212, 2016. ,
DOI : 10.1016/j.therap.2016.02.015
Careful Scrutiny of the Evidence for Drug-Drug Interactions in Clinical Decision Support Systems Is Necessary, Journal of Managed Care Pharmacy, vol.17, issue.9, p.713, 2011. ,
DOI : 10.18553/jmcp.2011.17.9.713
Stockley??s Drug Interactions, Critical Care Medicine, vol.34, issue.11, p.2873, 2006. ,
DOI : 10.1097/01.CCM.0000243724.78879.8F
M??canismes des interactions m??dicamenteuses d???origine pharmacocin??tique, La Revue de M??decine Interne, vol.31, issue.2, pp.170-179, 2010. ,
DOI : 10.1016/j.revmed.2009.07.009
[cité 16 sept 2017] Disponible sur: https://pharmacomedicale.org/index.php?option=com_content&view=article&id=102:variations- du-metabolisme-hepatique-des-medicaments&catid=45&Itemid=301 ,
Membrane transporter proteins: a challenge for CNS drug development, Dialogues Clin Neurosci, vol.8, issue.3, pp.311-332, 2006. ,
What do drug transporters really do?, Nature Reviews Drug Discovery, vol.12, issue.1, pp.29-44, 2015. ,
DOI : 10.1002/ibd.20849
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750486/pdf
Pharmacocin??tique et m??tabolisme des m??dicaments, EMC - Trait?? de m??decine AKOS, vol.1, issue.1, pp.1-6, 1998. ,
DOI : 10.1016/S1634-6939(06)75132-8
Interaction ciclosporinecisapride chez une patiente transplantée pulmonaire, J Pharm Clin. 12 févr, vol.21, issue.4, pp.291-294, 2003. ,
Disponible sur: http://www.theriaque.org/apps/interaction/itr_interaction.php 23, 2017. ,
Pharmacokinetics and Brain Penetration of Imatinib Mesylate (Gleevec): Implications for the Use of Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors to Enable the Brain Penetration of Imatinib in Patients, Cancer Research, vol.65, issue.7, pp.2577-82, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-2416
Progestatif contraceptif [Internet]. [cité 16 sept 2017, Disponible sur ,
Optimisation de l???efficacit?? des inhibiteurs de prot??ase par ????boosting????, M??decine et Maladies Infectieuses, vol.33, issue.S2, pp.111-117, 2003. ,
DOI : 10.1016/S0399-077X(02)00477-8
Exploration des fonctions tubulaires r??nales, N??phrologie & Th??rapeutique, vol.5, issue.1, pp.68-83, 2009. ,
DOI : 10.1016/j.nephro.2008.03.004
Disponible sur: http://www.theriaque.org/apps/interaction/itr_interaction.php 37. VIDAL - Naloxone [Internet]. [cité 16 sept 2017]. Disponible sur: https://www.vidal.fr/substances, 38. Interactions médicamenteuses -ANSM [Internet]. [cité 16 sept 2017]. Disponible sur, 2017. ,
Comparative assessment of four drug interaction compendia, British Journal of Clinical Pharmacology, vol.41, issue.6, pp.709-723, 2007. ,
DOI : 10.1331/154434504773062573
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2006.02809.x/pdf
des essais clinique : un plaidoyer pour une pharmacoépidémiologie pour tous ,
Histoire de la pharmacovigilance, Th??rapie, vol.71, issue.2, pp.123-131, 2016. ,
DOI : 10.1016/j.therap.2016.02.026
Pharmacovigilance fran??aise??: missions, organisation et perspectives, Th??rapie, vol.71, issue.2, pp.135-177, 2016. ,
DOI : 10.1016/j.therap.2016.02.028
Les effets indésirables des médicaments [Internet]. [cité 9 juill 2016]. Disponible sur ,
Pharmacovigilance : assurer la sécurité d'emploi des médicaments [Internet], Disponible sur, 2004. ,
La pharmacovigilance europ??enne??: place du Comit?? pour l?????valuation des risques en mati??re de pharmacovigilance (Pharmacovigilance Risk Assessment Committee???????PRAC) dans l???organisation et le processus d??cisionnel, Th??rapie, vol.71, issue.2, pp.151-60, 2016. ,
DOI : 10.1016/j.therap.2015.10.001
Role of serotonin 5-HT2C and histamine H1 receptors in antipsychotic-induced diabetes: A pharmacoepidemiological-pharmacodynamic study in VigiBase, European Neuropsychopharmacology, vol.25, issue.10, pp.1556-65, 2015. ,
DOI : 10.1016/j.euroneuro.2015.07.010
Imputabilit?? en pharmacovigilance??: de la m??thode fran??aise originelle aux m??thodes r??actualis??es, Th??rapie, vol.71, issue.2, pp.171-179, 2016. ,
DOI : 10.1016/j.therap.2016.02.009
La pharmacovigilance et??l'??valuation du??risque m??dicamenteux: int??r??t, fonctionnement et??m??thodes, Revue du Rhumatisme, vol.73, issue.10-11, pp.10-111021, 2006. ,
DOI : 10.1016/j.rhum.2006.09.008
Généralités sur la notification spontanée : quoi, qui, pourquoi, comment, quand, où ? ,
Disponible sur: http://www.ansm.sante.fr/var/ansm_site/storage/original/application/e40e2860ec6fe38f8708cfda ab704b65.pdf 57. Health care in the elderly: report of the Technical Group on Use of Medicaments by the Elderly, World Health Organization. Drugs. oct, vol.22, issue.4, pp.279-94, 1981. ,
Connaissance des effets indésirables des médicaments : pour une pharmacovigilance plus ambitieuse ,
La polymédication : définitions, mesures et enjeux. Questions d'économie de la santé, pp.1-8, 2014. ,
Les prescriptions des médecins généralistes et leurs déterminants, Etudes Résultats, issue.440, pp.1-12, 2005. ,
La consommation de médicaments dans les principaux pays industrialisés, Etudes Résultats, issue.47, pp.1-8, 2000. ,
Consensus Recommendations for Systematic Evaluation of Drug???Drug Interaction Evidence for Clinical Decision Support, Drug Safety, vol.2, issue.3, pp.197-206, 2015. ,
DOI : 10.1331/154434504773062591
Fr??quence et gravit?? des interactions m??dicamenteuses dans une population ??g??e: ??tude prospective concernant 639 malades, La Revue de M??decine Interne, vol.10, issue.6, pp.515-535, 1989. ,
DOI : 10.1016/S0248-8663(89)80069-4
Interactions médicamenteuses : à propos d'une étude prospective pilote en médecine générale libérale, Thérapie. juin, vol.55, issue.3, pp.395-403, 2000. ,
Interactions médicamenteuses potentielles en médecine générale : comparaison de deux études transversales en, Thérapie, vol.68, issue.6, p.3, 1997. ,
Potentiel d'étude de la base ACT-IP : illustration avec les interactions médicamenteuses, J Pharm Clin. 1 nov, vol.26, issue.4, pp.261-267, 2007. ,
Drug-drug and drug-disease interactions in the ED: Analysis of a high-risk population, The American Journal of Emergency Medicine, vol.14, issue.5, pp.447-50, 1996. ,
DOI : 10.1016/S0735-6757(96)90147-3
Incidence and Possible Causes of Prescribing Potentially Hazardous/Contraindicated Drug Combinations in General Practice, Drug Safety, vol.45, issue.1, pp.67-80, 2005. ,
DOI : 10.2165/00002018-200528010-00005
Clinically important potential drug-drug interactions in outpatient settings, Research in Social and Administrative Pharmacy, vol.3, issue.4, pp.426-463, 2007. ,
DOI : 10.1016/j.sapharm.2006.12.002
Drug-drug interactions among recently hospitalised patients ??? frequent but mostly clinically insignificant, European Journal of Clinical Pharmacology, vol.11, issue.9, pp.675-81, 2005. ,
DOI : 10.1080/00325481.1992.11701373
Prevalence and predictors of potential drug???drug interactions in Regione Emilia-Romagna, Italy, Journal of Clinical Pharmacy and Therapeutics, vol.15, issue.2, pp.141-51, 2008. ,
DOI : 10.2165/00002018-200528050-00001
Prevalence of drug???drug interactions at hospital entry and during hospital stay of patients in internal medicine, European Journal of Internal Medicine, vol.19, issue.6, pp.413-433, 2008. ,
DOI : 10.1016/j.ejim.2007.12.002
Frequency and nature of drug-drug interactions in a Dutch university hospital, British Journal of Clinical Pharmacology, vol.15, issue.2, pp.187-93, 2009. ,
DOI : 10.1097/00003643-199803000-00009
Drug-drug interactions in a cohort of hospitalized elderly patients, Pharmacoepidemiology and Drug Safety, vol.22, issue.13, pp.1054-60, 2013. ,
DOI : 10.1016/j.jacc.2009.05.050
Clinical relevance of drug-drug interactions in hospitalized dermatology patients, Adv Clin Exp Med Off Organ Wroclaw Med Univ. août, vol.22, issue.4, pp.555-63, 2013. ,
Potential Drug-Drug Interactions in Infant, Child, and Adolescent Patients in Children's Hospitals, PEDIATRICS, vol.135, issue.1, pp.99-108, 2015. ,
DOI : 10.1542/peds.2014-2015
URL : http://pediatrics.aappublications.org/content/pediatrics/135/1/e99.full.pdf
Potential drug???drug interactions in internal medicine wards in hospital setting in Pakistan, International Journal of Clinical Pharmacy, vol.7, issue.3, pp.455-62, 2013. ,
DOI : 10.1186/1472-6963-7-147
Evaluation of Potential Drug - Drug Interactions in General Medicine Ward of Teaching Hospital in Southern India, JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, vol.9, issue.2, pp.10-13, 2015. ,
DOI : 10.7860/JCDR/2015/11264.5608
Les interactions m??dicamenteuses en clinique??: ??tude prospective ciblant un service de cardiologie, Le Pharmacien Hospitalier et Clinicien, vol.49, issue.2, pp.2-6, 2014. ,
DOI : 10.1016/j.phclin.2014.04.227
Prevalence of potential drug???drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia, Asian Pacific Journal of Tropical Biomedicine, vol.4, issue.S1, pp.204-212, 2014. ,
DOI : 10.12980/APJTB.4.2014C1172
Possibility of Drug-Drug Interaction in Prescription Dispensed by Community and Hospital Pharmacy, Pharmacology & Pharmacy, vol.05, issue.04, p.5401, 2014. ,
DOI : 10.4236/pp.2014.54048
Hospitalisations and emergency department visits due to drug???drug interactions: a literature review, Pharmacoepidemiology and Drug Safety, vol.289, issue.6, pp.641-51, 2007. ,
DOI : 10.1111/j.1365-2125.1992.tb04001.x
Clinical Weighting of Drug-Drug Interactions in Hospitalized Elderly, Basic & Clinical Pharmacology & Toxicology, vol.114, issue.37 Pt 2, pp.298-305, 2016. ,
DOI : 10.1111/bcpt.12185
Understanding adverse drug reactions in older adults through drug???drug interactions, European Journal of Internal Medicine, vol.25, issue.9, pp.843-849, 2014. ,
DOI : 10.1016/j.ejim.2014.10.001
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study, Fundamental & Clinical Pharmacology, vol.88, issue.1, pp.106-117, 2015. ,
DOI : 10.1016/j.mayocp.2013.03.006
Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug???drug interactions: a PharmacoVigilance study in France, European Journal of Clinical Pharmacology, vol.11, issue.4, pp.885-893, 2013. ,
DOI : 10.1517/14740338.2012.631910
How many potential drug???drug interactions cause adverse drug reactions in hospitalized patients?, European Journal of Internal Medicine, vol.24, issue.1, pp.27-33, 2013. ,
DOI : 10.1016/j.ejim.2012.09.011
Actual drug???drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study, European Journal of Clinical Pharmacology, vol.61, issue.9, pp.1717-1741, 2013. ,
DOI : 10.1007/s11096-008-9191-x
Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study, J Pharm Pharm Sci Publ Can Soc Pharm Sci Soc Can Sci Pharm, vol.15, issue.2, pp.332-375, 2012. ,
Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database, European Journal of Clinical Pharmacology, vol.24, issue.1, pp.633-674, 2011. ,
DOI : 10.1097/00007691-200202000-00016
URL : https://hal.archives-ouvertes.fr/hal-00661924
Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions, Drug Safety, vol.76, issue.8, pp.667-75, 2010. ,
DOI : 10.1111/j.1532-5415.1996.tb01865.x
Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study, Croatian Medical Journal, vol.52, issue.5, pp.604-618, 2011. ,
DOI : 10.3325/cmj.2011.52.604
Adverse drug events in an intensive care unit of a university hospital, European Journal of Clinical Pharmacology, vol.39, issue.7???8, pp.625-657, 2011. ,
DOI : 10.1345/aph.1E642
Adverse drug reactions detected by stimulated spontaneous reporting in an internal medicine department in Romania, European Journal of Internal Medicine, vol.21, issue.5, pp.453-460, 2010. ,
DOI : 10.1016/j.ejim.2010.05.014
Polypharmakotherapie und unangemessene Verschreibung bei ??lteren internistischen Patienten in ??sterreich, Wiener klinische Wochenschrift, vol.55, issue.23-24, pp.23-24733, 2008. ,
DOI : 10.7326/0003-4819-147-11-200712040-00006
Drug-Drug Interactions in a Geriatric Outpatient Cohort, Drugs & Aging, vol.143, issue.2, pp.343-55, 2008. ,
DOI : 10.1007/BF03083579
Drug-drug interactions - a preventable patient safety issue?, British Journal of Clinical Pharmacology, vol.28, issue.Suppl. 1, pp.144-150, 2008. ,
DOI : 10.1111/j.1365-2125.2007.02981.x
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2007.02981.x/pdf
A pharmacoepidemiologic study of drug interactions in a Brazilian teaching hospital, Clinics, vol.61, issue.6, pp.515-535, 2006. ,
DOI : 10.1590/S1807-59322006000600005
A new nomenclature for classifying psychotropic drugs, British Journal of Clinical Pharmacology, vol.172, issue.8, pp.1614-1620, 2017. ,
DOI : 10.1111/bph.13347
état des lieux, synthèse et surveillance : rapport [Internet]. 2014 [cité 17 sept 2017]. Disponible sur: http://ansm.sante.fr/Dossiers/Lesanticoagulants/Les-anticoagulants-en-France-Etudes-et-surveillance, 2014. ,
Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients*, Clinical Pharmacology & Therapeutics, vol.23, issue.1, pp.64-78, 1998. ,
DOI : 10.1002/cpt196910122
Les bases pharmacologiques de la th??rapeutique. Analyse pharmacologique du r??sum?? des caract??ristiques d???un produit ( le ?? RCP ??) pour le th??rapeute, Th??rapie, vol.70, issue.5, pp.403-417, 2015. ,
DOI : 10.2515/therapie/2015025
M??dicaments et fragilit?? chez les personnes ??g??es. Vers une nouvelle entit????: la fragilit?? pharmacologique???, Th??rapie, vol.71, issue.3, pp.275-284, 2016. ,
DOI : 10.1016/j.therap.2016.02.021